LAFOX, Ill., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Richardson Electronics, Ltd. (NASDAQ: RELL) plans to release its financial results for its second quarter ended November 29, 2025, after the close of business on Wednesday, January 7, 2026. The release will be distributed by GlobeNewswire and will be available on the Company’s website at www.rell.com.
NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Live Oak Bancshares, Inc. (“Live Oak” or the “Company”) (NYSE: LOB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Alibaba Group Holding Limited (“Alibaba” or the “Company”) (NYSE: BABA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Plug Power Inc. (“Plug” or the “Company”) (NASDAQ: PLUG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
BRIGHTON, Mich, Dec. 30, 2025 (GLOBE NEWSWIRE) -- CGE Energy, Inc. (OTC: CGEI) today announced the issuance of the following year end update letter from its President and Chief Executive Officer, Bryan Zaplitny.
SEATTLE, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
MIAMI BEACH, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Herzfeld Credit Income Fund, Inc. (NASDAQ: HERZ) (the “Fund”) today announced that the Fund has made the following year-end distribution:
HOUSTON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Kirby Corporation ("Kirby") (NYSE: KEX) will announce its 2025 fourth quarter results at 6:00 a.m. Central Standard Time (“CST”) on Thursday, January 29, 2026. This announcement will be followed by an earnings conference call webcast at 7:30 a.m. CST.
MENLO PARK, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:30 AM PT (1:30 PM ET) in San Francisco, California.
SUNNYVALE, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation will take place on Monday, January 12, 2026, at 9:00 am Pacific Standard Time / 12:00 pm Eastern Sta...
NORTHFIELD, Ill., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are scheduled to present at the J.P. Morgan Healthcare Conference in San Francisco, Calif., on Tuesday, January 13, 2026, at 3:00 pm Pacific Time.
Terah Krigsvold to replace Andrea Goren as CFO, who is named chief business officer and CEO of INVO Centers LLC to focus on growth efforts Terah Krigsvold to replace Andrea Goren as CFO, who is named chief business officer and CEO of INVO Centers LLC to focus on growth efforts
PONTE VEDRA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that John T. Treace, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, beginning at approximately 7:30 am PT.
If approved, DTX401 will be the first therapy approved to treat the underlying cause of GSDIa If approved, DTX401 will be the first therapy approved to treat the underlying cause of GSDIa
NEW YORK (dpa-AFX) - Der legendäre US-Investor Warren Buffett zieht sich in dieser Woche aus dem operativen Tagesgeschäft seines US-Finanz- und Industriekonglomerats Berkshire Hathaway zurück. Die Leitung des Konzerns übernimmt US-Medien zufolge sei...
Chefsache Künstliche Intelligenz: Nvidia wird Teil einer Regierungsmission, um das Land besser zu schützen und Medikamente schneller zu entwickeln. Die Aktie hat 2025 zur starken Performance des Depot 2030 beigetragen – heute gibt es einen KI-Kauf für 2026.
Der von Warren Buffett aufgebaute Investmentriese steht vor einer neuen Führungsära. Nach Jahrzehnten an der Spitze übergibt der wohl berühmteste Investor der Welt schrittweise das Ruder.
Tesla Inc. once propelled a little-known South Korean family into the ranks of the ultra-rich on a landmark supply deal. But as the contract fell short of expectations, it became a drag on a fortune that was already under pressure — with the full extent only now becoming clear.
Nordea Bank AbpStock exchange release – Changes in company’s own shares30.12.2025 at 22.30 EETNordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 30.12.2025 completed repurchases of own shares (ISIN: FI4000297767) as follows:+----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+------...
Interview details Company’s gold-backed stablecoin growth strategy, revenue opportunities, and vision for shareholder value Interview details Company’s gold-backed stablecoin growth strategy, revenue opportunities, and vision for shareholder value
On today’s Big Take Asia podcast, how China went from fears of a lost decade to an AI-fueled comeback — and what its resilience means for global markets in 2026.
Keine Bank in Deutschland wächst so schnell wie Trade Republic. Die Digitalbank überzeugt Millionen Kunden – doch ihr Geschäftsmodell hat auch Schattenseiten.